Company news
Gb Sciences, Inc. (OTC:GBLX) news
Gb Sciences, Inc. news releases on 6ix. Latest, Apr 4, 2018: GB Sciences Completes Nanotechnology Transfer of Exclusively-Licensed, Cannabinoid-Based…
Press releases — page 3
GB Sciences Completes Nanotechnology Transfer of Exclusively-Licensed, Cannabinoid-Based, Time-Released Neuropathic Pain Formula
April 4, 2018
GB Sciences Signs Letter of Intent to Acquire NevadaPURE's Las Vegas Operations: Gaining $16 Million in Annualized Revenues
March 28, 2018
GB Sciences Sponsors "Innovation in Medical Cannabis Therapies" Symposium
March 15, 2018
GB Sciences, Inc. Enters A New Market by Signing a Contract Farming Agreement for the Development of Boutique Hemp Genetics with the Colorado Hemp Project
February 27, 2018
GB Sciences Receives Issuance of Its Cannabis Oil Production License
February 21, 2018
GB Sciences Partners with Wellcana Group, LLC. in the Development of Medical Cannabis in Louisiana
February 14, 2018
John Poss, Chief Executive Officer of GB Sciences, Inc., Returns to Uptick Newswire’s “Stock Day” Podcast with Everett Jolly for Operational Update
February 6, 2018
GB Sciences Files a Nonprovisional Patent Application for Cannabis-Based Anti-Inflammatory Therapies Including Arthritis, Asthma, Eczema and More
February 5, 2018
GB Sciences Welcomes Dr. Zoltan Mari, A Nationally Recognized Expert on the Study and Treatment of Parkinson's Disease to Their Scientific Advisory Board
January 25, 2018
GB Sciences' Chief Science Officer, Dr. Andrea Small-Howard, Has Been Invited to Join the Medical Cannabis in Neuroscience Panel at The Neuroscience Innovation Forum for BD&L and Investment in Therapeutics and Technology
December 26, 2017
GB Sciences: Develops Extremely High THC Content Cannabis Strain With Maximized Terpene Levels To Increase Medical Benefits
December 13, 2017
Uptick Newswire “Stock Day” Interviews John Poss CEO of GB Sciences on the Company’s Cannabis Tiers, Medical and Recreational
December 12, 2017
GB Sciences Announces Tissue Propagation Breakthrough In Commercial Cannabis Cultivation
December 5, 2017
GB Sciences Exceeds Its Gross Revenue Projections for October, Doubles the Industry Average Yield Per Active Flower Light
November 15, 2017
GB Sciences is Happy
November 13, 2017
GB Sciences Inducts Scientific Advisory Board: Dr. Andrea Small-Howard of GB Sciences, Dr. Helen Turner of Chaminade University, Dr. Norbert Kaminsky of Michigan State University, and Dr. Carlos Ríos-Bedoya of McLaren Health
November 2, 2017
GB Sciences, Inc. Partners With Cura Cannabis Solutions And Enters The Lucrative Cannabis Oil Market In Nevada
October 30, 2017
GB Sciences Receives The Prestigious 'Spirit Of The Law' Award
October 26, 2017
GB Sciences Increased Sales 400% Since First Harvest
October 23, 2017
GB Sciences Obtains Exclusive Worldwide License on a Time-Released Cannabinoid Formulation for Neuropathic Pain
October 17, 2017
Nanotechnology Research Collaboration with Universidad de Sevilla to Create Time-Released Formulation for GB Sciences' THC-Free Chronic Pain Therapy
October 10, 2017
Groundbreaking Collaboration Between A Major University And A Medical Cannabis Company
September 18, 2017
Innovative Partnership Forged Between LSU AgCenter And GB Sciences To Advance The Understanding Of The Cannabis Plant
September 18, 2017
GB Sciences Joins With Los Coyotes Band Of Cahuilla And Cupeno Indians As It Enters The Gigantic California Cannabis Market
August 2, 2017
GB Sciences Initiates Cannabis-based Therapy Clinical Trials Consulting Services Agreement with Worldwide Clinical Trials, Inc.
July 17, 2017
GB Sciences Inc. Adds Provisional Nevada Recreational Cannabis License for Branded Recreational Products
July 10, 2017
GB Sciences Sells First Cannabis Harvest and Officially Enters Revenue Mode
July 5, 2017
GB Sciences Wins Louisiana State University (LSU) Bid to Act as LSU Agricultural Center's Exclusive Operator of Medical Cannabis Production Facility
June 26, 2017
GB Sciences Announced As LSU Bid Winner
June 16, 2017
GB Sciences Builds Broad Cannabis Patent Portfolio -- CFN Media
June 16, 2017
GB Sciences Files Patent Application for Chronic Pain and Heart Therapies
May 23, 2017
GB Sciences, Inc. Announces The Appointment Of Mr. Leslie Bocskor As Vice Chairman
May 22, 2017
GB Sciences Celebrates Their First Las Vegas Harvest
May 16, 2017
GB Sciences Revered Founder, Craig Ellins, Retires
May 7, 2017
GB Sciences Surpasses Key Corporate Milestones, Plus Exclusive CEO Interview -- CFN Media
May 2, 2017
GB Sciences Partners with Kush Cups to Produce Cannabis-Infused Keurig-Compatible K-Cups, Brewed Coffee and Infused Tea
April 10, 2017
GB Sciences Submits Offer to Louisiana State University (LSU) for Providing the Cultivation, Extraction, Processing and Production of Medical Cannabis Pursuant to the Alison Neustrom Act
April 3, 2017
GB Sciences Moves Closer to Clinical Trials -- CFN Media
March 28, 2017
Why Cannabinoids Work Best Together -- CFN Media
March 7, 2017
GB Sciences Embraces Cannabinoid Complexities, Plus New Interview -- CFN Media
February 9, 2017
GB Sciences Files Patent Application for the Treatment of Chronic Arthritis, Crohn's Disease, Inflammatory Bowel Disease, and Asthma; Proprietary Cannabinoid-Containing Complex Mixtures for the Treatment of Inflammatory Disorders
February 6, 2017
GB Sciences Resets: Exclusive Executive Interview with CFN Media
January 23, 2017
GB Sciences (GBLX): A Grow Business with a Moonshot in Biopharma -- CFN Media
January 6, 2017